Russia pledges to modernize pharma, expand domestic sector

04/30/2013 | In-PharmaTechnologist.com

Russia plans to establish six model "biopharma" centers, facilitate the adherence by domestic drug manufacturers to international good manufacturing practices by next year, and ensure that Russian drugmakers control 50% of the market by 2020, according to Sergey Tsyb of the Russian Ministry of Industry and Trade. Tsyb, who spoke last week at the BIO International Convention in Chicago, said, "We are here to facilitate new collaborations and remind our international colleagues that the Russian pharma sales environment is healthy and we are open to collaboration."

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA